<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MOTIVATION: Discrimination between two classes such as <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples and between two types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> based on gene expression profiles is an important problem which has practical implications as well as the potential to further our understanding of gene expression of various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Classification or discrimination of more than two groups or classes (multi-class) is also needed </plain></SENT>
<SENT sid="2" pm="."><plain>The need for multi-class discrimination methodologies is apparent in many microarray experiments where various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types are considered simultaneously </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Thus, in this paper we present the extension to the classification methodology proposed earlier Nguyen and Rocke (2002b; Bioinformatics, 18, 39-50) to classify <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples from multiple classes </plain></SENT>
<SENT sid="4" pm="."><plain>The methodologies proposed in this paper are applied to four gene expression data sets with multiple classes: (a) a hereditary <z:hpo ids='HP_0003002'>breast cancer</z:hpo> data set with (1) BRCA1-mutation, (2) BRCA2-mutation and (3) <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0003002'>breast cancer</z:hpo> samples, (b) an <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> data set with (1) <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), (2) T-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) and (3) B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) samples, (c) a <z:hpo ids='HP_0002665'>lymphoma</z:hpo> data set with (1) diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), (2) B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCLL</z:e>) and (3) follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) samples, and (d) the NCI60 data set with cell lines derived from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> of various sites of origin </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we evaluated the classification algorithms and examined the variability of the error rates using simulations based on randomization of the real data sets </plain></SENT>
<SENT sid="6" pm="."><plain>We note that there are other methods for addressing multi-class prediction recently and our approach is along the line of Nguyen and Rocke (2002b; Bioinformatics, 18, 39-50) </plain></SENT>
<SENT sid="7" pm="."><plain>CONTACT: dnguyen@stat.tamu.edu; dmrocke@ucdavis.edu </plain></SENT>
</text></document>